Regulated Cannabis And Hemp Market Navigation

Embark on a transformative journey through uncharted realms of research and industry with the first book of the "Cannabis Innovations" series. This multidisciplinary effort breaks the mold of typical cannabis texts by providing chapters written by a diverse array of professionals actively shaping the frontiers of cannabis science and business. Regulatory consultants, lawyers, pharmacologists, industry operators, and academics unite to offer seldom encountered perspectives found in traditional cannabis discourse. Our compilation is a carefully curated exploration of the advanced and interconnected complexities of cannabis and is tailored for those with a foundational understanding, ready to delve deeper into the subject. This is part of a larger DeGruyter initiative which focuses on innovative and novel topics, each volume of this series serves as a guide through the multifaceted landscape of cannabis. Step into a pragmatic view of the cannabis industry’s future, where research and innovation converge to advance our understanding of this complex plant, helping us become poised to balance the risks and benefits for the challenges that lay ahead.

This book provides an in-depth resource for the cannabis industry - from the cultivation, manufacturing, and product quality to the distribution, and use of cannabis products. It examines the four main areas of the industry: plant science, medical science, regulatory and legal issues, and business issues. This approach provides entrepreneurs, scientists, and healthcare practitioners the necessary tools to navigate this new and exciting space.

Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.

From the leading authority on marijuana—a man who has served as White House advisor on drugs to three different administrations and who NBC News once called “the prodigy of drug politics"—comes the remarkable and shocking exposé about how 21st century pot, today’s new and highly potent form of the drug, is on the rise, spreading rapidly across America by an industry intent on putting rising profits over public health. Smokescreen: What the Marijuana Industry Doesn't Want You to Know examines the inside story behind the headlines, containing accounts from Sabet’s time in the Obama administration to stunning revelations from whistleblowers speaking out for the first time. What it finds is how the marijuana industry is running rampant without proper oversight, leaving Americans’ health seriously at risk. Included are interviews with industry insiders who reveal the hidden dangers of a product they had once worshipped. Also contained in these pages are insights from a major underground-market dealer who admits that legalization is hastening the growth of the illicit drug trade. And more to the heart of the issue are the tragic stories of those who have suffered and died as a result of marijuana use, and in many cases, as a result of its mischaracterization. Readers will learn how power brokers worked behind the scenes to market marijuana as a miracle plant in order to help it gain widespread acceptance and to set the stage for the lucrative expansion of recreational pot. The author of this compelling first-person narrative leading the national fight against the legalization of cannabis through his nonprofit, Smart Approaches to Marijuana (aka SAM) is Kevin Sabet. As a policy advisor to everyone from county health commissioners to Pope Francis, and a frequent public speaker on television, radio and through other media outlets, his analysis is consistently relied upon by those who recognize what’s at stake as marijuana lobbyists downplay the risks of massive commercialization. A book several years in the making, filled with vivid characters and informed by hundreds of interviews and scores of confidential documents, Sabet's Smokescreen lays bare the unvarnished truth about marijuana in America.

As the largely illicit cannabis market transitions to a legal, regulated industry, the "canna-curious" and experienced industry participants alike are experiencing the harsh truth: Making a fortune in the legal cannabis industry is a challenge made even more difficult by a complex patchwork of state and federal laws. The Cannabis Business clears the confusion around topics such as the distinction between hemp and cannabis and why it matters for consumers and regulators, why CBD isn’t completely legal in the U.S., why and how states differ in their licensing processes, and how deal structuring is impacted by state regulations. Written by attorneys from the nation’s leading cannabis law and policy firm, this comprehensive primer on all things cannabis law is a must-have for anyone seeking to understand the major practical legal issues facing the cannabis industry in the U.S.

How the future of post-legalization marijuana farming can be sustainable, local, and artisanal. What will the marijuana industry look like as legalization spreads? Will corporations sweep in and create Big Marijuana, flooding the market with mass-produced weed? Or will marijuana agriculture stay true to its roots in family farming, and reflect a sustainable, local, and artisanal ethic? In Craft Weed, Ryan Stoa argues that the future of the marijuana industry should be powered by small farms—that its model should be more craft beer than Anheuser-Busch. To make his case for craft weed, Stoa interviews veteran and novice marijuana growers, politicians, activists, and investors. He provides a history of marijuana farming and its post-hippie resurgence in the United States. He reports on the amazing adaptability of the cannabis plant and its genetic gifts, the legalization movement, regulatory efforts, the tradeoffs of indoor versus outdoor farms, and the environmental impacts of marijuana agriculture. To protect and promote small farmers and their communities, Stoa proposes a Marijuana Appellation system, modeled after the wine industry, which would provide a certified designation of origin to local crops. A sustainable, local, and artisanal farming model is not an inevitable future for the marijuana industry, but Craft Weed makes clear that marijuana legalization has the potential to revitalize rural communities and the American family farm. As the era of marijuana prohibition comes to an end, now is the time to think about what kind of marijuana industry and marijuana agriculture we want. Craft Weed will help us plan for a future that is almost here.

A volume in the Emerging Issues in Analytical Chemistry series, The Analytical Chemistry of Cannabis: Quality Assessment, Assurance, and Regulation of Medicinal Marijuana and Cannabinoid Preparations provides analytical chemistry methods that address the latest issues surrounding cannabis-based products. The plethora of marketed strains of cannabis and cannabinoid-containing products, combined with the lack of industry standards and labelling requirements, adds to the general perception of poor quality control and limited product oversight. The methods described in this leading-edge volume help to support the manufacturing, labelling, and distribution of safe and consistent products with known chemical content and demonstrated performance characteristics. It treats analytical chemistry within the context of the diverse issues surrounding medicinal and recreational cannabis in a manner designed to foster understanding and rational perspective in non-scientist stakeholders as well as scientists who are concerned with bringing a necessary degree of order to a field now characterized by confusion and contradiction. The Emerging Issues in Analytical Chemistry series is published in partnership with RTI International and edited by Brian F. Thomas. Please be sure to check out our other featured volumes: Hackney, Anthony C. Exercise, Sport, and Bioanalytical Chemistry: Principles and Practice, 9780128092064, March 2016. Tanna, Sangeeta and Lawson, Graham. Analytical Chemistry for Assessing Medication Adherence, 9780128054635, April 2016. Rao, Vikram, Knight, Rob, and Stoner, Brian. Sustainable Shale Oil and Gas: Analytical Chemistry, Biochemistry, and Geochemistry Methods, 9780128103890, forthcoming September 2016. Farsalinos, Konstantinos, et al. Analytical Assessment of e-Cigarettes: From Contents to Chemical and Particle Exposure Profiles, 9780128112410, forthcoming November 2016. Addresses current and emerging analytical chemistry methods—an approach that is unique among the literature on this topic Presents information from a broad perspective of the issues in a single compact volume Employs language comprehensible to non-technical stakeholders as well as to specialists in analytical chemistry

This book explores one of the most pressing public policy questions for the 2020s: how should we regulate cannabis? The global cannabis prohibition regime is fragmenting as more countries experiment with decriminalization and legalization, and this book aims to make sense of this rapidly changing world. The ‘cannabis challenge’ is complex. How do we balance creating a potentially lucrative legal cannabis industry with protecting public health? How do we hardwire social and racial justice into our reform initiatives? How do we build a cannabis trade that is environmentally sustainable? The book seeks to make sense of our present through a state-of-the-art global review of cannabis law reform initiatives – mapping what has been done, where, and with what impacts. It attempts to generate new ideas for the future of cannabis regulation by viewing it through the lens of business regulation and learning lessons from how other consumer products are regulated.